Transce3nd LLC bought a new position in The Clorox Company (NYSE:CLX – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 473 shares of the company’s stock, valued at approximately $77,000.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Brooklyn Investment Group boosted its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Redwood Park Advisors LLC bought a new position in shares of Clorox during the fourth quarter valued at about $26,000. Millstone Evans Group LLC purchased a new position in shares of Clorox in the fourth quarter worth about $31,000. Asset Planning Inc purchased a new stake in Clorox during the 4th quarter valued at about $32,000. Finally, GKV Capital Management Co. Inc. bought a new position in Clorox during the 4th quarter worth approximately $32,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Clorox Trading Down 0.9 %
NYSE CLX opened at $138.59 on Tuesday. The stock’s fifty day moving average price is $146.36 and its 200-day moving average price is $156.20. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a market cap of $17.07 billion, a P/E ratio of 37.87, a P/E/G ratio of 2.62 and a beta of 0.61. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.52%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s payout ratio is currently 133.33%.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on CLX shares. Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $173.00 to $151.00 and set a “neutral” rating for the company in a research note on Friday, April 11th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Citigroup cut their price objective on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research report on Monday, April 14th. Finally, UBS Group decreased their target price on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $153.83.
View Our Latest Stock Report on CLX
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Transportation Stocks Investing
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- There Are Different Types of Stock To Invest In
- Why Call Option Traders Are Targeting This Dividend ETF Now
- Why Invest in High-Yield Dividend Stocks?
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.